CGEN insider buying and SEC filings, explained
Compugen Ltd. · CIK 1119774
Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- L3
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$118K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 9, 2026 | Planned (10b5-1) | Zurit Levine (SVP, Business Development) sold 1,875 shares at $2.50 ($5K), marked as a 10b5-1 plan trade. Holdings down 6% to 29,375 shares. | SEC filing Filed Jul 13, 2026 |
| Apr 24, 2026 | Planned (10b5-1) | Zurit Levine (SVP, Business Development) sold 2,000 shares at $3.20 ($6K), marked as a 10b5-1 plan trade. Holdings down 6% to 29,375 shares. | SEC filing Filed Apr 27, 2026 |
| Apr 24, 2026 | Planned (10b5-1) | Eran Ophir (CEO and Director) sold 5,000 shares at about $3.20 ($16K), marked as a 10b5-1 plan trade. Holdings down 31% to 11,375 shares. | SEC filing Filed Apr 27, 2026 |
| Apr 14, 2026 | Planned (10b5-1) | Eran Ophir (CEO and Director) sold 5,000 shares at about $2.90 ($15K), marked as a 10b5-1 plan trade. Holdings down 31% to 11,375 shares. | SEC filing Filed Apr 15, 2026 |
| Apr 14, 2026 | Planned (10b5-1) | Zurit Levine (SVP, Business Development) sold 2,000 shares at $2.80 ($6K), marked as a 10b5-1 plan trade. Holdings down 6% to 29,375 shares. | SEC filing Filed Apr 15, 2026 |
| Apr 10, 2026 | Planned (10b5-1) Amended filing | Zurit Levine (SVP, Business Development) sold 3,125 shares at about $2.56 ($8K), marked as a 10b5-1 plan trade. Holdings down 10% to 29,375 shares. This amends a filing from Apr 13. | SEC filing Filed Apr 15, 2026 |
| Apr 7–8, 2026 | Planned (10b5-1) | Zurit Levine (SVP, Business Development) sold 7,875 shares between Apr 7 and Apr 8 at about $2.38 ($19K), marked as a 10b5-1 plan trade. Holdings down 21% to 29,375 shares. | SEC filing Filed Apr 9, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Zurit Levine (SVP, Business Development) sold 3,500 shares at $2.20 ($8K), marked as a 10b5-1 plan trade. Holdings down 11% to 29,375 shares. | SEC filing Filed Apr 3, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Eran Ophir (CEO and Director) sold 5,625 shares at about $2.21 ($12K), marked as a 10b5-1 plan trade. Holdings down 33% to 11,375 shares. | SEC filing Filed Apr 3, 2026 |
| Mar 26, 2026 | Planned (10b5-1) | Zurit Levine (SVP, Business Development) sold 11,875 shares at about $2.04 ($24K), marked as a 10b5-1 plan trade. Holdings down 29% to 29,375 shares. | SEC filing Filed Mar 30, 2026 |
22 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CGEN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.